NHS trust in London; one of England’s largest, linking five hospitals with Imperial College London
A UK NHS study indicates focal therapy provides durable long‑term cancer control for many prostate cancer patients, with just two of 3,477 men dying from prostate cancer a decade after treatment and lower side‑effects. The government is expanding access to more centres.